Combination of doses, better than monotherapy for pulmonary hypertension

Published Date: 08 Mar 2023

People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

2.

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

3.

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

4.

Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know

5.

Skipping Lymph Node Biopsy Gains Ground in Breast Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot